AI filing briefs · archive

8-K filings in April 2025, explained

811 material Form 8-K filings that 685 companies we cover made with the SEC in April 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

7 of 811 briefs match

newest first · times in ET
OGNOrganon & Co. Apr 15, 5:05 PM ET

Organon appoints Ramona A. Sequeira to board, effective July 1, 2025

Neutral leadership Written later 5.027.01

Organon & Co. said its board will expand by one seat to 12 directors, and Ramona A. Sequeira will fill the new seat effective July 1, 2025. Sequeira is a former Eli Lilly and Takeda executive, and she will join the board's Talent Committee, which may matter to shareholders as a change in board composition.

  • Board size increases by one, to 12 directors, effective July 1, 2025.
  • Ramona A. Sequeira previously spent 20 years at Eli Lilly and 10 years at Takeda, where she is President of the Global Portfolio Division.
  • Sequeira will serve on the Talent Committee and receive pro-rated cash compensation for 2025 under the director compensation program.
Read the filing on SEC.gov ↗
LADLITHIA MOTORS INC Apr 15, 5:00 PM ET

Lithia Motors: COO Adam Chamberlain to resign June 1, 2025 to become Mercedes-Benz USA CEO

Neutral leadership Written later 5.02

Lithia Motors said Executive Vice President and Chief Operating Officer Adam A. Chamberlain will resign effective June 1, 2025 to become CEO of Mercedes-Benz USA. Regional presidents and vice presidents will report directly to CEO Bryan DeBoer after his departure, so the change affects the company's operating structure at the senior level.

  • Adam A. Chamberlain's resignation as EVP and Chief Operating Officer is effective June 1, 2025.
  • Chamberlain is moving to become CEO of Mercedes-Benz USA.
  • Regional presidents and regional vice presidents will report directly to Bryan DeBoer, Chief Executive Officer.
  • The filing was signed April 15, 2025 by David Stork, Chief Administrative Officer and Senior Vice President.
Read the filing on SEC.gov ↗
CVLTCOMMVAULT SYSTEMS INC Apr 15, 4:58 PM ET

Commvault Refinances Credit Line, Raising Borrowing Capacity to $300 Million

Neutral financing Written later 1.011.022.03

Commvault Systems entered a new five-year senior secured revolving credit facility on April 15, 2025, replacing its $100 million facility and lifting total borrowing capacity to $300 million. The filing also says the prior December 13, 2021 credit agreement was terminated as part of the refinancing.

  • New five-year senior secured revolving credit facility gives total borrowing capacity of $300 million, up from $100 million.
  • Borrowings priced at SOFR plus 1.50% to 2.00%, or base rate plus 0.50% to 1.00%, with margins tied to the leverage ratio.
  • Unused commitment fee of 0.25% to 0.35% per year; agreement includes leverage and interest coverage maintenance covenants.
  • Credit agreement is administered by JPMorgan Chase Bank, N.A.; the prior agreement dated December 13, 2021 was terminated.
Read the filing on SEC.gov ↗
ALHCAlignment Healthcare, Inc. Apr 15, 4:38 PM ET

Alignment Healthcare: Chief Experience Officer Hakan Kardes resigns, effective immediately

Neutral leadership Written later 5.02

Alignment Healthcare said its Chief Experience Officer, Hakan Kardes, resigned to pursue other professional opportunities. The resignation took effect immediately, but he will stay employed through May 16, 2025 to help transfer his duties to other senior employees.

  • Hakan Kardes notified the company of his resignation on April 9, 2025.
  • Resignation as Chief Experience Officer was effective immediately.
  • Kardes remains employed through May 16, 2025 to facilitate the transition of duties.
Read the filing on SEC.gov ↗

Arrowhead CFO Ken Myszkowski to retire May 13; Daniel Apel named successor

Neutral leadership Written later 5.02

Arrowhead Pharmaceuticals said CFO Ken Myszkowski will retire effective May 13, 2025, after serving as CFO since 2009, and will stay on as an employee adviser through January 31, 2026. Daniel Apel, formerly Global Head of Financial Planning and Analysis at Walgreens Boots Alliance, will succeed him as CFO. The company describes the retirement as not the result of any disagreement.

  • Ken Myszkowski retires as CFO effective May 13, 2025; he has served as CFO since 2009
  • Daniel Apel appointed CFO; target bonus set at 45% of base salary
  • Apel to receive a one-time grant of 100,000 restricted stock units vesting annually over four years, plus up to $200,000 in relocation benefits
  • Myszkowski's transition adviser role runs until January 31, 2026, at a $200,000 annual base salary
Read the filing on SEC.gov ↗

First American names CFO Mark Seaton CEO after Ken DeGiorgio's departure

Neutral leadership Written later 5.02

First American Financial Corporation said Chief Executive Officer Kenneth D. DeGiorgio left the company and its board, effective April 10, 2025, and his employment was terminated without cause. The board promoted Chief Financial Officer Mark E. Seaton to CEO and appointed him a director, and promoted Treasurer Matthew F. Wajner to CFO, both effective the same day.

  • Kenneth D. DeGiorgio ceased to serve as CEO and director effective April 10, 2025; his employment was terminated without cause
  • Mark E. Seaton, 47, was promoted to CEO and appointed a director effective April 10, 2025; he had been CFO since 2013
  • Matthew F. Wajner, 49, was promoted to CFO effective April 10, 2025; he had been Vice President, Treasurer since 2020
  • DeGiorgio may receive compensation under his February 18, 2025 employment agreement, subject to an effective release of claims
Read the filing on SEC.gov ↗
UAAUnder Armour, Inc. Apr 15, 8:33 AM ET

Under Armour appoints Dawn Fitzpatrick, Eugene Smith and Robert Sweeney to board

Neutral leadership Written later 5.02

Under Armour added three new directors to its board effective April 15, 2025: Dawn N. Fitzpatrick, Eugene D. Smith and Robert J. Sweeney. The company expects to assign them to board committees effective May 1, 2025, and each will receive restricted stock units under the company's director compensation plan, which matters to shareholders as a change in board composition and director pay.

  • Fitzpatrick and Sweeney are expected to join the Audit Committee and the Finance and Capital Planning Committee; Smith is expected to join the Corporate Governance and Sustainability Committee and the Human Capital and Compensation Committe
  • Each new director receives an initial restricted stock unit award valued at $100,000 and a pro-rated annual award valued at $62,500, with a grant date of April 15, 2025.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.